SÜSS MicroTec

Jefferies cut its price target from €109 to €84 and Deutsche Bank Research from €100 to €94; both keep their rating at 'Buy'. The reasons are strong demand and a production relocation plan from Garching to Zhubei, which means some revenues are now expected only in 2027. The stock reacted positively, rising in XETRA trading at times about 5.3% to €52.90. » More on finanzen.net

Suss MicroTec lowers its 2026 sales forecast to €405–425 million and reduces the expected EBIT margin to 5–7%, despite a record-high order book. Parts of production will be moved to Zhubei (Taiwan) and Sternenfels, production at the Garching site will be discontinued; R&D and the corporate headquarters will remain in Germany. One-off costs of around €6.2 million as well as timing shifts and component shortages are said to explain much of the margin deterioration; the gross margin remains unchanged at 35–37%. Whether revenues are only delayed or permanently lost depends on the success of the production move and the easing of supply chains; 2027 will be the litmus test. » More on finanzen.net

Suss Microtec is halting production in Garching and will concentrate manufacturing in Zhubei (Taiwan) and Sternenfels; about 70 jobs are affected. The company expects one‑off costs of €6.2 million and revenue shifts due to the relocation and supply bottlenecks. For 2026 it lowered the revenue forecast to €405–425 million (previously €425–485 million) and the EBIT margin to 5–7% (previously 8–10%). The order book reached a record high in the third quarter; R&D, central production units and the group headquarters will remain in Germany. » More on finanzen.net